<div id="readability-page-1"><p>Columbus Macro LLC boosted its stake in shares of  Cardinal Health, Inc. (NYSE:CAH - Free Report) by 102.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor  owned 36,529 shares of the company's stock after purchasing an additional 18,516 shares during the period. Columbus Macro LLC's holdings in Cardinal Health were worth $5,734,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>Cardinal Health</strong> alerts:</span></p></div><ul><li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li></ul><p>A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp grew its holdings in shares of  Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter.  Atlantic Edge Private Wealth Management LLC boosted its position in  Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company's stock valued at $29,000 after purchasing an additional 75 shares during the last quarter.  Vermillion &amp; White Wealth Management Group LLC grew its stake in  Cardinal Health by 55.0% in the second quarter. Vermillion &amp; White Wealth Management Group LLC now owns 200 shares of the company's stock valued at $34,000 after purchasing an additional 71 shares in the last quarter.  NewSquare Capital LLC increased its position in  Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company's stock worth $36,000 after purchasing an additional 107 shares during the last quarter.  Finally, AlphaCore Capital LLC purchased a new stake in shares of  Cardinal Health during the 2nd quarter worth about $41,000. Hedge funds and other institutional investors own  87.17% of the company's stock. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of research firms recently commented on CAH. UBS Group increased their price objective on Cardinal Health from $185.00 to $220.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, October 31st. Evercore ISI increased their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an &#34;outperform&#34; rating in a research note on Friday, October 31st. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the company a &#34;hold&#34; rating in a research note on Tuesday, November 18th. Robert W. Baird  set a $232.00 target price on shares of Cardinal Health in a research report on Friday, October 31st. Finally, Leerink Partners raised their target price on Cardinal Health from $211.00 to $230.00 and gave the company an &#34;outperform&#34; rating in a report on Monday, November 17th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned  a Hold rating to the stock. According to MarketBeat, Cardinal Health  has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $209.00.</p><ul><li>Medical Technology Stock Benefits from Rising Acute Care Demand</li></ul><p><b>Get Our Latest Stock Report on Cardinal Health</b></p><h2>Cardinal Health Price Performance</h2><p>Shares of CAH opened at $208.19 on Friday. The company has a market capitalization of $49.46 billion, a PE ratio of 31.40, a price-to-earnings-growth ratio of 1.52 and a beta of 0.63. Cardinal Health, Inc. has a one year low of $117.53 and a one year high of $214.93. The company's fifty day moving average price is $196.29 and its 200 day moving average price is $170.14. </p><ul><li>For Cardinal Health, the Proof Will be in Its Performance</li></ul><p>Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analysts' expectations of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business's quarterly revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS.  Analysts anticipate that  Cardinal Health, Inc. will post 7.95 earnings per share for the current year. </p><h2>Cardinal Health Announces Dividend</h2><p>The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health's dividend payout ratio  is currently 30.77%. </p><h2>Cardinal Health Company Profile</h2> (Free Report)<p>Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.  </p><p>The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.</p><h2>See Also</h2><ul><li>Five stocks we like better than Cardinal Health</li><li>Wall Street Stockpicker Names #1 Stock of 2026</li><li>ALERT: Drop these 5 stocks before January 2026!</li><li>The $650 Million Bet on AI's Future</li><li>Nvidia x 1,000,000</li><li>GOLD ALERT</li></ul><p><strong>Want to see what other hedge funds are holding CAH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2><p>Before you consider Cardinal Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Columbus Macro LLC increased its stake in Cardinal Health by 102.8% in Q3, now holding 36,529 shares valued at $5.73 million. Other institutional investors also adjusted their positions. Analysts have given Cardinal Health a "Moderate Buy" rating with a consensus target price of $209.00. The company reported Q3 earnings of $2.55 per share, surpassing estimates, with revenue up 22.4% year-over-year. Cardinal Health announced a quarterly dividend of $0.5107 per share, payable on January 15th.</p>

Columbus Macro LLC Has $5.73 Million Position in Cardinal Health, Inc. $CAH